Skip to main content

MK-677 Risks

Meaning

MK-677 risks denote the potential adverse clinical effects and safety concerns associated with the use of Ibutamoren, a potent, non-peptide Growth Hormone Secretagogue (GHS), particularly when used outside of approved clinical trial settings. These risks, which necessitate careful patient monitoring, include potential metabolic disturbances such as impaired glucose tolerance, increased insulin resistance, and dose-dependent fluid retention, as well as possible elevations in prolactin and cortisol levels. A thorough risk-benefit assessment is required due to its systemic endocrine impact.